Invention Grant
US08772273B2 Formulations and uses of retinoic acid receptor selective agonists
有权
视黄酸受体选择性激动剂的制剂和用途
- Patent Title: Formulations and uses of retinoic acid receptor selective agonists
- Patent Title (中): 视黄酸受体选择性激动剂的制剂和用途
-
Application No.: US13253014Application Date: 2011-10-04
-
Publication No.: US08772273B2Publication Date: 2014-07-08
- Inventor: Ferenc Makra
- Applicant: Ferenc Makra
- Applicant Address: US CA Palo Alto
- Assignee: QuRetino Therapeutics, Inc.
- Current Assignee: QuRetino Therapeutics, Inc.
- Current Assignee Address: US CA Palo Alto
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/19 ; A61K31/35 ; A61K31/21 ; A61K9/14
Abstract:
The invention provides retinoic acid receptor (RAR) selective agonists and formulations thereof for the treatment of disease or for inducing a medically beneficial effect.
Public/Granted literature
- US20130085166A1 FORMULATIONS AND USES OF RETINOIC ACID RECEPTOR SELECTIVE AGONISTS Public/Granted day:2013-04-04
Information query
IPC分类:
